ÓÅÓιú¼Ê¡¤UB8(ÖйúÓÎ)¼¯ÍŹٷ½ÍøÕ¾

Ϊ½øÒ»²½´î½¨²úѧÑÐÏàÖúƽ̨£¬£¬£¬£¬£¬Íƶ¯¾«×¼Ò½ÁƿƼ¼Ð§¹ûת»¯£¬£¬£¬£¬£¬½ñÌ죬£¬£¬£¬£¬“2021ÄêµÚÎå½ì¹ú¼Ê¾«×¼Ò½ÁÆѧÊõÄê»áÓ빤ҵ´ó»á”£¨ÒÔϼò³Æ“¾«×¼Ò½ÁÆ´ó»á”£©ÔÚÉϺ£ÕÙ¿ª£¬£¬£¬£¬£¬±¾½ì´ó»áÓÉÖйúÒ½Ò©ÉúÎïÊÖÒÕЭ»á¾«×¼Ò½ÁÆ·Ö»áÖ÷Àí£¬£¬£¬£¬£¬ÉϺ£´óѧÁ¥ÊôÃϳ¬Ö×ÁöÒ½Ôº¡¢ÉϺ£´óѧÓÅÓιú¼Ê¡¤UB8(ÖйúÓÎ)¼¯ÍŹٷ½ÍøÕ¾ÖÎÁÆÁ¢ÒìÑо¿ÔººÍÉϺ£ÓÅÓιú¼Ê¡¤UB8(ÖйúÓÎ)¼¯ÍŹٷ½ÍøÕ¾ÖÎÁƹ¤³ÌÊÖÒÕÑо¿ÖÐÐijаì¡£¡£¡£¡£¡£»£»£»£»£»£»£»£»áÉÏ£¬£¬£¬£¬£¬ÖйúÒ½Ò©ÉúÎïÊÖÒÕЭ»áÏòµ¼Î⳯êÍΪ±¾´Î´ó»áÖ´ǣ¨ÔÚÏßÐÎʽ£©£¬£¬£¬£¬£¬²¢ÖÂÒÔÕæÖ¿µÄ×£¸£¡£¡£¡£¡£¡£´ó»áÊܵ½¼Î¶¨ÇøÕþ¸®¡¢ÉϺ£´óѧÏòµ¼Ãǵĸ߶ÈÖØÊÓºÍÖ§³Ö¡£¡£¡£¡£¡£

¿ªÄ»Ê½ÉÏ£¬£¬£¬£¬£¬È«ÌåÓë»áÖ°Ô±ÆðÁ¢Ä¬°§£¬£¬£¬£¬£¬Ë¼Äî¡¢Ö¾´Öйú“¾«×¼Ò½Ñ§”ÏÈÇýÕß——ÎâÃϳ¬ÔºÊ¿£¬£¬£¬£¬£¬ÎâÀϽ¨ÉèÁËÖйúÒ½Ò©ÉúÎïÊÖÒÕЭ»á¾«×¼Ò½ÁƷֻᣬ£¬£¬£¬£¬²¢µ£µ±µÚÒ»½ì¾«×¼Ò½ÁÆ·Ö»áµÄÖ÷ÈÎίԱ¡£¡£¡£¡£¡£

±¾½ì¾«×¼Ò½ÁÆ´ó»áÒÔ“Á¢Ö×Áö¾«×¼Ò½ÁÆ»ùʯ£¬£¬£¬£¬£¬´´ÃâÒßÓÅÓιú¼Ê¡¤UB8(ÖйúÓÎ)¼¯ÍŹٷ½ÍøÕ¾ÖÎÁÆΰҵ”ΪÖ÷Ì⣬£¬£¬£¬£¬½ÓÄÉÖ±²¥¼°Â¼²¥µÄ·½·¨£¬£¬£¬£¬£¬Í¨¹ýÏßÉÏÏßϵÄÐÎʽÁª¶¯º£ÄÚÍâÒ»Á÷Á¢ÒìÑз¢¿Æѧ¼Ò¡¢ÁÙ´²ÕïÖÎר¼Ò¡¢Õï¶Ï¼ì²âÊÖÒÕÐÐÒµ¼°¹¤Òµ½ç¾«Ó¢£¬£¬£¬£¬£¬Î§Èƹ¤ÒµÉú³¤¡¢¿Æ¼¼Á¢Òì¡¢ÁÙ´²Êµ¼ùµÈÕö¿ªÆÕ±é¶øÉîÈëµØ̽ÌÖ£¬£¬£¬£¬£¬²¢ÍŽᵱϺ£ÄÚÍâÉú³¤ÐÂÐÎÊÆ£¬£¬£¬£¬£¬ÌØÊâÊÇÔÚйÚÒßÇéµÄÓ°ÏìÏ£¬£¬£¬£¬£¬Æð¾¢¼ÓÈëÓ¦¶Ô¾«×¼Ò½ÁÆÐÂÊÖÒÕµÄÌôÕ½£¬£¬£¬£¬£¬ÅäºÏÍƽøÎÒ¹ú¾«×¼Ò½ÁÆÁìÓòÊÖÒÕÁ¢ÒìºÍ¿çÁìÓòЭ×÷£¬£¬£¬£¬£¬ÎªÈËÀ࿵½¡×ö³öТ˳¡£¡£¡£¡£¡£

ͼ£ºÉϺ£ÓÅÓιú¼Ê¡¤UB8(ÖйúÓÎ)¼¯ÍŹٷ½ÍøÕ¾ÖÎÁÆÑо¿ÔºÔº³¤¡¢ÉϺ£´óѧҽѧԺ¸±Ôº³¤

Ç®Æä¾ü½ÌÊÚ½ÒÏþÖ÷ÌâÑݽ²

ÉϺ£ÓÅÓιú¼Ê¡¤UB8(ÖйúÓÎ)¼¯ÍŹٷ½ÍøÕ¾ÖÎÁÆÑо¿ÔºÔº³¤¡¢ÉϺ£´óѧҽѧԺ¸±Ôº³¤Ç®Æä¾ü½ÌÊÚÔÚ»áÉϽÒÏþ¡¶¸ßËÙÉú³¤ÓÅÓιú¼Ê¡¤UB8(ÖйúÓÎ)¼¯ÍŹٷ½ÍøÕ¾¼°»ùÒòÖÎÁƹ¤ÒµÕýÔÚÀ´ÁÙ¡·Ö÷ÌâÑݽ²£¬£¬£¬£¬£¬ËûÌåÏÖ£¬£¬£¬£¬£¬“ÓÅÓιú¼Ê¡¤UB8(ÖйúÓÎ)¼¯ÍŹٷ½ÍøÕ¾¼°»ùÒòÖÎÁÆÕýÖð²½³ÉΪҽѧµÄÈý´óÖ§ÖùÖ®Ò»£¬£¬£¬£¬£¬ÓÅÓιú¼Ê¡¤UB8(ÖйúÓÎ)¼¯ÍŹٷ½ÍøÕ¾ÖÂÁ¦ÓÚÓÅÓιú¼Ê¡¤UB8(ÖйúÓÎ)¼¯ÍŹٷ½ÍøÕ¾¼°»ùÒòÖÎÁƵÄԭʼÁ¢Ò죬£¬£¬£¬£¬½â¾öÓÅÓιú¼Ê¡¤UB8(ÖйúÓÎ)¼¯ÍŹٷ½ÍøÕ¾¼°»ùÒòÖÎÁƵē¿¨²±×Ó”¹¤³Ì£¬£¬£¬£¬£¬½«ÏÖÔÚ¼ÛÇ®ÌÚ¹óµÄÓÅÓιú¼Ê¡¤UB8(ÖйúÓÎ)¼¯ÍŹٷ½ÍøÕ¾¼°»ùÒòÖÎÁÆÒ©ÎïÉú³¤³ÉΪͨË×ÀÏÀèÃñÓõÃÆðµÄ²úÆ·£¬£¬£¬£¬£¬ÕæÕý×ÊÖúÖ×Áö»¼Õ߿ɼ°”¡£¡£¡£¡£¡£

ͼ£ºÉϺ£´óѧÁ¥ÊôÃϳ¬Ö×ÁöÒ½ÔºÔº³¤³Ì´«Ãç½ÌÊÚÖ´Ç

ÉϺ£´óѧÁ¥ÊôÃϳ¬Ö×ÁöÒ½ÔºÔº³¤³Ì´«Ãç½ÌÊÚΪ±¾´Î´ó»áÖ´Ç¡£¡£¡£¡£¡£ÏÖ³¡´Ó¶Ô³ÌÔº³¤·Ã̸ÖÐÏàʶµ½£¬£¬£¬£¬£¬ÔçÔÚ2012Ä꣬£¬£¬£¬£¬µÚÈý½ì¡¶¿µ¸´·ÉúÃüÐÂÖª¡·Ò½Ñ§¸ß¶ËÂÛ̳ÉÏ£¬£¬£¬£¬£¬ÔÚ“Öйú¸Îµ¨Íâ¿ÆÖ®¸¸”ÎâÃϳ¬ÔºÊ¿µÄÏòµ¼ÏÂÌá³ö“Ñ°ÕÒҽѧ¿ÆѧµÄ‘ÌìÖ÷Á£×Ó’ÊÇ‘¾«×¼Ò½Ñ§’”£¬£¬£¬£¬£¬Æð¾¢Íƶ¯º£ÄÚ¾«×¼Ò½ÁÆ·Ö»áµÄ½¨ÉèºÍÉú³¤¡£¡£¡£¡£¡£2013Ä꣬£¬£¬£¬£¬Ç®Æä¾ü½ÌÊÚ½¨ÉèÓÅÓιú¼Ê¡¤UB8(ÖйúÓÎ)¼¯ÍŹٷ½ÍøÕ¾£¬£¬£¬£¬£¬¾­ÓɶàÄêʵ¼ùºÍ̽Ë÷£¬£¬£¬£¬£¬Ç®½ÌÊÚÏòµ¼ÍŶӽ«“ÓÅÓιú¼Ê¡¤UB8(ÖйúÓÎ)¼¯ÍŹٷ½ÍøÕ¾¿µ½¡¡¢ÓÅÓιú¼Ê¡¤UB8(ÖйúÓÎ)¼¯ÍŹٷ½ÍøÕ¾Ò©Îï¡¢Ö×ÁöÒ½ÁÆ”¾ÙÐÐÉî¶ÈÈںϣ¬£¬£¬£¬£¬¹¹½¨“³¬µÈÓÅÓιú¼Ê¡¤UB8(ÖйúÓÎ)¼¯ÍŹٷ½ÍøÕ¾³x·¢ÏµÍ³”£¬£¬£¬£¬£¬´òÔìÓÅÓιú¼Ê¡¤UB8(ÖйúÓÎ)¼¯ÍŹٷ½ÍøÕ¾ÖÎÁÆÁìÓòµÄ“ÈýλһÌå”Õ½ÂÔ±Õ»·£¬£¬£¬£¬£¬Îª¿µ½¡ÈËȺ¡¢ÑÇ¿µ½¡ÈËȺÒÔ¼°Ö×Áö¼²²¡»¼Õߣ¬£¬£¬£¬£¬Ìṩ²î±ðÐèÇó¡¢²î±ð²ãÃæµÄ¿µ½¡Ö§³ÖºÍÕïÁÆЧÀÍ¡£¡£¡£¡£¡£ÉϺ£´óѧÁ¥ÊôÃϳ¬Ö×ÁöÒ½ÔºÁ¥ÊôÓÚÓÅÓιú¼Ê¡¤UB8(ÖйúÓÎ)¼¯ÍŹٷ½ÍøÕ¾£¬£¬£¬£¬£¬ÊÇ“ÈýλһÌå”Õ½ÂÔ±Õ»·ÖÐÓÅÓιú¼Ê¡¤UB8(ÖйúÓÎ)¼¯ÍŹٷ½ÍøÕ¾Ò½ÁÆ¿µ½¡µÄÂäµØ»·½Ú£¬£¬£¬£¬£¬³ÐÔØ×ÅÓÅÓιú¼Ê¡¤UB8(ÖйúÓÎ)¼¯ÍŹٷ½ÍøÕ¾ÖÎÁÆÁÙ´²Ñо¿ºÍת»¯µÄÖ÷ҪʹÃü¡£¡£¡£¡£¡£¾­Óɶ̶ÌÒ»ÄêµÄÉú³¤£¬£¬£¬£¬£¬Ò½ÔºÔÚÁÙ´²¡¢¿ÆÑм°È˲ŵȷ½ÃæÓëÉϺ£´óѧ½¨ÉèÉî¶ÈÏàÖú£»£»£»£»£»£»£»£»³ÉΪ“¾«×¼Ò½ÁƷֻᔵÄÖ÷ίµ¥Î»£»£»£»£»£»£»£»£»Í¬Ê±£¬£¬£¬£¬£¬Í¨¹ý¾ÙÐеēŵ½±ÂÛ̳”Ô¼Çëŵ±´¶û½±¸÷¸öÁìÓòµÃÖ÷Ç°À´¾ÙÐпÆÑÐÏàÖúºÍѧÊõ½»Á÷£¬£¬£¬£¬£¬ÔÚÔºÄÚÐγÉÁËÓÅÒìµÄѧÊõ½»Á÷Æø·Õ£¬£¬£¬£¬£¬ÎüÒýÁËÖڶຣÄÚÍâÖøÃûר¼ÒºÍÓÅÒìÈ˲ŵļÓÈë¡£¡£¡£¡£¡£

ͼ£º2021ÄêµÚÎå½ì¹ú¼Ê¾«×¼Ò½ÁÆѧÊõÄê»áÓ빤ҵ´ó»á

¿Õ¾ü¾üÒ½´óѧ¹ú¼Ò·Ö×Óҽѧת»¯¿ÆѧÖÐÐÄÖ÷ÈγÂÖ¾ÄÏԺʿ¾Û½¹COVID-19ÒÔÊÓƵÔÚÏßµÄÐÎʽ½ÒÏþÌâΪNew Strategies for Preventing & Treating COVID-19 Induced by SARS-CoV-2 VariantsµÄÖ÷ÌâÑݽ²¡£¡£¡£¡£¡£°©Ö¢ÖÎÁÆÒѽøÈ뾫׼ҽÁÆʱ´ú£¬£¬£¬£¬£¬ÆäÖÐÒÔCAR-TΪ´ú±íµÄÓÅÓιú¼Ê¡¤UB8(ÖйúÓÎ)¼¯ÍŹٷ½ÍøÕ¾ÃâÒßÖÎÁÆ£¬£¬£¬£¬£¬±»ÓþΪ¾«×¼´Ý»Ù°©ÓÅÓιú¼Ê¡¤UB8(ÖйúÓÎ)¼¯ÍŹٷ½ÍøÕ¾µÄ“ÌØÖÖ×÷Õ½²½¶Ó”¡£¡£¡£¡£¡£

ͼ£ºÉϺ£´óѧÁ¥ÊôÃϳ¬Ö×ÁöÒ½ÔºÓªÒµÔº³¤¡¢Ô­MD°²µÂÉ­°©Ö¢Ñо¿ÖÐÐÄÖÕÉí½ÌÊںͻùÒò¼ì²âÈÏÕæÈË

Áõ²ý¹¦½ÌÊÚ½ÒÏþÖ÷ÌâÑݽ²

»áÉÏ£¬£¬£¬£¬£¬ÉϺ£´óѧÁ¥ÊôÃϳ¬Ö×ÁöÒ½ÔºÓªÒµÔº³¤¡¢Ô­MD°²µÂÉ­°©Ö¢Ñо¿ÖÐÐÄÖÕÉí½ÌÊںͻùÒò¼ì²âÈÏÕæÈËÁõ²ý¹¦½ÌÊÚ£¬£¬£¬£¬£¬½ÒÏþÁËCancer and Genomics in Precision MedicineÖ÷ÌâÑݽ²¡£¡£¡£¡£¡£´Ó»ùÒò×éѧ½Ç¶ÈÆÊÎöÁ˾«×¼Ò½Ñ§¶Ô°©Ö¢µÄÒâÒå¡£¡£¡£¡£¡£ËûÒÔΪ£¬£¬£¬£¬£¬»ùÒò×éѧÊÇ°©Ö¢¾«×¼Ò½ÁÆÒªÁìµÄ»ù´¡ºÍ½¹µã£¬£¬£¬£¬£¬¶Ô°©Ö¢µÄÕï¶ÏºÍÖÎÁÆÓÐÖØ´óÒâÒå¡£¡£¡£¡£¡£´ÓÕï¶ÏµÄ½Ç¶ÈÀ´½²£¬£¬£¬£¬£¬ÏÖÔÚÖ»ÓÐÉÙÊý¼¸ÖÖ°©Ö¢¿ÉÒÔʹÓþ«×¼É¸²é¿ªÕ¹ÔçÆÚÕï¶Ï¡£¡£¡£¡£¡£»£»£»£»£»£»£»£»ùÒò×éѧµÄÉú³¤Ê¹¶Ô¶àÖÖ°©Ö¢µÄÔçÆÚɸ²é³ÉΪ¿ÉÄÜ¡£¡£¡£¡£¡£»£»£»£»£»£»£»£»ùÓÚ»ùÒò×éѧµÄÐÂÐÍɸ²éÒªÁì°üÀ¨¶ÔÓÎÀëDNAÖУã£ô£Ä£Î£ÁÍ»±ä¼ì²â£¬£¬£¬£¬£¬ºÍ¼×»ù»¯¼ì²â¡£¡£¡£¡£¡££ã£ô£Ä£Î£ÁÊÇÓÎÀëÔÚÓÅÓιú¼Ê¡¤UB8(ÖйúÓÎ)¼¯ÍŹٷ½ÍøÕ¾ÍâµÄ£¬£¬£¬£¬£¬°©ÓÅÓιú¼Ê¡¤UB8(ÖйúÓÎ)¼¯ÍŹٷ½ÍøÕ¾Ëù±¬·¢µÄ£Ä£Î£ÁƬ¶Ï¡£¡£¡£¡£¡£Î¢´´ÒºÌå»î¼ì¼´¿ÉÍê³É¶Ô£ã£ô£Ä£Î£ÁµÄ¼ì²â£¬£¬£¬£¬£¬¶Ô°©Ö¢ÔçɸºÍ¿µ½¡¼à²âÓÐÖØ´óÒâÒå¡£¡£¡£¡£¡£¼×»ù»¯ÔÙ±í¹ÛÒÅ´«Ñ§ÖУ¬£¬£¬£¬£¬ÊǶÔDNAµÄ»¯Ñ§ÐÞÊΡ£¡£¡£¡£¡£ÕâЩÐÞÊÎÄܾöÒé»ùÒòµÄ·­¿ªÕվɹرÕ¡£¡£¡£¡£¡£¶à¸ö°©ÖÖ£¬£¬£¬£¬£¬Èç·Î°©£¬£¬£¬£¬£¬¶¼Óë·ÇÕý³£µÄ¼×»ù»¯Ïà¹Ø¡£¡£¡£¡£¡£½èÖú»ùÒòµÄ¼×»ù»¯¼ì²â£¬£¬£¬£¬£¬Î´À´¿ÉÒÔʵÏÖ¶àÖÖ°©Ö¢µÄɸ²é¡£¡£¡£¡£¡£

ͼ£º2021ÄêµÚÎå½ì¹ú¼Ê¾«×¼Ò½ÁÆѧÊõÄê»áÓ빤ҵ´ó»á

±ðµÄ£¬£¬£¬£¬£¬±öϦ·¨ÄáÑÇ´óѧÖÕÉí½ÌÊÚ¡¢ÃÀ¹ú¿ÆѧԺԺʿCarl JuneÒÔÊÓƵÔÚÏßµÄÐÎʽΧÈÆCAR-TÓÅÓιú¼Ê¡¤UB8(ÖйúÓÎ)¼¯ÍŹٷ½ÍøÕ¾µÄ¾«×¼Ò½Ñ§½ÒÏþPrecision Medicine with CAR-T Cells-Clinical perspective and significanceÖ÷ÌâÑݽ²£¬£¬£¬£¬£¬²¢ÐðÊöÁËÓÅÓιú¼Ê¡¤UB8(ÖйúÓÎ)¼¯ÍŹٷ½ÍøÕ¾ÁÆ·¨µÄÏÖʵÒâÒå¡£¡£¡£¡£¡£ÉúÎïоƬÉϺ£¹ú¼Ò¹¤³ÌÑо¿ÖÐÐÄÖ÷ÈÎÛ¬ºã¿¥½ÌÊÚ¡¢Í¬¼Ã´óѧÁ¥ÊôµÚÊ®ÈËÃñÒ½ÔºÖ×Áö¿ÆÖ÷ÈÎÐíÇà½ÌÊÚ¡¢¸´µ©´óѧÁ¥ÊôÎ÷ÔÀÒ½ÔºÖ×Áö¿ÆÖ÷ÈÎÁºÏþ»ª½ÌÊÚ¡¢¸´µ©´óѧÁ¥ÊôÖ×ÁöÒ½Ôº·ÅÁÆ¿ÆÖ÷ÈÎÖìÕý·É¡¢ÉϺ£½»´óÁ¥ÊôµÚÒ»ÈËÃñÒ½ÔºÖÐÐÄʵÑéÊÒÖ÷ÈλÆÙ»½ÌÊÚ¡¢ºÓÄÏÊ¡Ö×ÁöÒ½ÔºÃâÒßÖÎÁÆ¿ÆÖ÷ÈθßÈ«Á¢½ÌÊÚ¡¢ÄÏ·½Ò½¿Æ´óѧÁ¥ÊôÄÏ·½Ò½Ôº¾«×¼Ò½Ñ§ÖÐÐÄÖ÷ÈÎÎâ±þÒå½ÌÊÚ¡¢Ö£ÖÝ´óѧÁ¥ÊôµÚÒ»Ò½ÔºÖ×Áö¿ÆÖ÷ÈÎÕÅÒã½ÌÊÚ¡¢ÉϺ£½»Í¨´óѧÁ¥ÊôÈʼÃÒ½ÔºÖ÷ÈÎҽʦ¸ð½¨Î°µÈ¶àλר¼Ò»®·Ö´Ó¸÷×ÔÑо¿ÁìÓò³ö·¢£¬£¬£¬£¬£¬½ÒÏþÁ˶ÔÖ×ÁöÁÆ·¨µÄ×îп´·¨£¬£¬£¬£¬£¬²¢´Ó¶àά¶ÈÕö¿ªÉîÈë̽ÌÖ£¬£¬£¬£¬£¬Í¨¹ý¿çÁìÓòµÄÍ·ÄÔ½»Á÷Òý·¢Ð¿´·¨£¬£¬£¬£¬£¬Íƶ¯¹¤ÒµÁ¢ÒìÉú³¤£¬£¬£¬£¬£¬Ôö½øÈËÀ࿵½¡¸£ìí¡£¡£¡£¡£¡£